UK markets closed

Abbott Laboratories (ABL.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
98.40+0.59 (+0.60%)
At close: 05:35PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 170.83B
Enterprise value 178.21B
Trailing P/E 32.78
Forward P/E 22.68
PEG ratio (5-yr expected) 5.73
Price/sales (ttm)4.56
Price/book (mrq)4.72
Enterprise value/revenue 4.42
Enterprise value/EBITDA 17.13

Trading information

Stock price history

Beta (5Y monthly) 0.74
52-week change 3-3.48%
S&P500 52-week change 325.77%
52-week high 3111.28
52-week low 385.56
50-day moving average 3104.25
200-day moving average 398.59

Share statistics

Avg vol (3-month) 3609
Avg vol (10-day) 3492
Shares outstanding 51.74B
Implied shares outstanding 61.75B
Float 81.73B
% held by insiders 10.54%
% held by institutions 176.60%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42.07
Forward annual dividend yield 42.12%
Trailing annual dividend rate 32.12
Trailing annual dividend yield 32.17%
5-year average dividend yield 41.59
Payout ratio 464.80%
Dividend date 3N/A
Ex-dividend date 412 Apr 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 13.96%
Operating margin (ttm)15.40%

Management effectiveness

Return on assets (ttm)6.09%
Return on equity (ttm)14.76%

Income statement

Revenue (ttm)40.33B
Revenue per share (ttm)23.18
Quarterly revenue growth (yoy)2.20%
Gross profit (ttm)N/A
EBITDA 10.37B
Net income avi to common (ttm)5.61B
Diluted EPS (ttm)2.98
Quarterly earnings growth (yoy)-7.10%

Balance sheet

Total cash (mrq)6.65B
Total cash per share (mrq)3.82
Total debt (mrq)14.71B
Total debt/equity (mrq)37.66%
Current ratio (mrq)1.60
Book value per share (mrq)22.31

Cash flow statement

Operating cash flow (ttm)7.14B
Levered free cash flow (ttm)4.61B